The move indicated that the drug had cleared more rigorous hurdles since it was given emergency authorization in May.
A proposal announced by President Trump last month was to send older Americans $200 discount cards to offset prescription costs. It’s not going to happen before the election, and maybe not ever.
All the weak points of American health care — testing delays, communication breakdowns, inequity — are working against this potential treatment.
Critics said the study, sponsored by the W.H.O., was too poorly conducted to be definitive.
The two-drug combination invented by college students is one of many potential therapies being tested for this paralyzing fatal condition.
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.
Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
The months ahead will be difficult. But the medical cavalry is coming, and the rest of us know what we need to do.
Emergency-use authorizations, a formerly obscure corner of regulatory law, have become a centerpiece of the government’s response to the pandemic.
The “cell lines” used to develop monoclonal antibodies, as well as remdesivir and vaccines, began with fetal tissue decades ago.
An experimental antibody cocktail taken by the president has not yet been proven effective against the illness caused by the coronavirus.
The company said that doses of the unproven treatment would be available for 50,000 patients. It’s impossible to know whether it helped the president.
In a video on Wednesday evening, the president portrayed an unproven antibody cocktail being developed by the drug maker Regeneron as a miracle cure.
While the drug has not been shown to effectively treat Covid-19, many people on Twitter and Facebook urged President Trump to take it.
Many of the measures cited by his doctors are reserved for patients severely affected by the coronavirus.
Speed and scale may matter more than absolute effectiveness when it comes to tests, masks, treatments and vaccines.
Outside experts pointed to the therapies as signs that the president’s health may not be as good as his doctors said. His age, weight and gender put him at high risk.
Regeneron and Eli Lilly wouldn’t say whether Mr. Trump would receive their experimental antibody drugs. Regeneron’s C.E.O. has known the president for years.
Scientists are looking at the medicinal potential of plants and animals in the region’s vast tropical forests.
Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be.
Maybe! It may help with the common cold. There is no definitive scientific evidence suggesting it will help Covid-19.
The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
The U.S. insisted that new international guidelines on combating drug resistance omit any mention of fungicides — a demand that the industry made but that ran counter to science.
Benzodiazepines — commonly prescribed for anxiety, insomnia, seizures and panic disorders — are highly addictive and come with health risks, especially when combined with other drugs.
Unlike some of its competitors, Johnson & Johnson’s vaccine does not need to be frozen and may require just one shot instead of two.
While scientists are rushing to develop an immunization for adults, no one has started the process yet for children.
There is accumulating evidence that the benefits of statins far outweigh possible risks, and nearly all statins on the market are now available as inexpensive generics.
The White House and the pharmaceutical industry were nearing a major deal to lower drug prices. Then the administration demanded that $100 cash cards be sent to millions of seniors before the election — and the industry balked.
A so-called monoclonal antibody lowered levels of the coronavirus and prevented hospitalizations. The research has not yet been vetted by independent experts.
The order expands on a presidential promise by trying to reduce the prices Medicare pays for prescription drugs, but experts said it was unclear whether the White House could carry out the directive.
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.
New details of how the president has demanded faster action from health agencies help explain the intensifying concern that he could demand pre-Election Day approval of a vaccine.
A group of career scientists at the Food and Drug Administration vowed that their work would continue unimpeded and independent of political influence.
The president is the Coronavirus vaccine’s worst hype man.
The problem occurs when drug-induced side effects are viewed as a new ailment and treated with yet another drug that can cause still other side effects.
An experimental medication that increases height in children with the most common form of dwarfism has raised hope that it can help them lead easier lives. But some say the condition is not a problem in need of a cure.
The statement is meant to reassure the public that the companies will not seek a premature approval of vaccines under pressure from the Trump administration.
A study of their therapy and clinical trials of other experimental treatments are offering glimmers of hope that paralysis from the disorder can be slowed.
As President Trump pushes the possibility of a vaccine this year, the C.D.C. has outlined technical scenarios to state public health officials for an unidentified Vaccine A and Vaccine B.
More than 70,000 Covid-19 patients have received it. We have no idea whether it helps.
Meditation apps, tinctures, stress-busting gummies — spending on commercials for all of them is rising amid the pandemic’s climbing death toll and economic strain.
The agency’s chief spokeswoman, Emily Miller, was removed from her position just 11 days into the job. And the contract was terminated of a consultant who had advised the F.D.A. chief to correct misleading claims about plasma’s benefits.
Many experts — including a scientist who worked on the Mayo Clinic study — were bewildered about where a key statistic came from.
The president’s campaign has made his efforts to lower prescription drug prices a centerpiece of his re-election pitch, but the executive order remains unseen.
Sowing doubt about the safety of treatments will imperil the fight against coronavirus in the months and years to come.
The move came on the eve of the Republican convention and after President Trump pressed the agency to move faster to address the pandemic.
The chief executive of My Pillow, a Trump donor, claims oleandrin is a miracle cure for Covid-19. But no studies have shown that it is safe or effective, and the shrub it’s derived from is poisonous.
In addition to concerns over mail-in voting, the cost-cutting at the Postal Service affects the millions of people who get their prescriptions by mail.